Sun Wei Yue, Reiser Ira W, Chou Shyan-Yih
Division of Nephrology and Hypertension, Department of Medicine, The Brookdale University Hospital and Medical Center, Brooklyn, NY 11212, USA.
Am J Kidney Dis. 2006 May;47(5):798-808. doi: 10.1053/j.ajkd.2006.01.031.
In patients with congestive heart failure (CHF), continuous diuretic therapy may result in acute renal insufficiency (ARI). This study examines factors contributing to this complication.
We analyzed clinical data from 318 consecutive patients who were hospitalized for CHF. All were treated with diuretics and had echocardiography performed within 4 days of hospitalization. Systolic left ventricular (LV) dysfunction is defined as an ejection fraction less than 50%, and diastolic LV dysfunction, as an ejection fraction of 50% or greater in the presence of LV hypertrophy and a reversed E/A ratio.
ARI, defined as a 25% increase in serum creatinine level, occurred in 110 patients (35%) after diuretic therapy. Risk factors for ARI on univariate analyses were older age, higher baseline serum creatinine level, lower baseline serum sodium level, lower mean arterial pressure (MAP) during diuretic therapy, and greater doses and longer duration of diuretic therapy. In multivariate analyses, ARI occurred more frequently in patients with systolic (40%) than diastolic dysfunction (28%). The use of digoxin in patients with systolic LV dysfunction was observed to decrease the risk for ARI by 61%, independent of other agents used for the treatment of patients with CHF.
Age, baseline renal function and serum sodium concentration, MAP, and intensity of diuretic therapy can identify individuals at risk for ARI while receiving diuretic therapy for CHF. This complication is observed more often in individuals with systolic dysfunction, and its risk may be decreased with the use of digoxin.
在充血性心力衰竭(CHF)患者中,持续利尿治疗可能导致急性肾功能不全(ARI)。本研究探讨了导致这一并发症的因素。
我们分析了318例因CHF住院的连续患者的临床资料。所有患者均接受利尿剂治疗,并在住院4天内进行了超声心动图检查。收缩期左心室(LV)功能障碍定义为射血分数低于50%,舒张期LV功能障碍定义为在存在LV肥厚和E/A比值倒置的情况下射血分数为50%或更高。
在利尿剂治疗后,110例患者(35%)出现了定义为血清肌酐水平升高25%的ARI。单因素分析中ARI的危险因素包括年龄较大、基线血清肌酐水平较高、基线血清钠水平较低、利尿剂治疗期间平均动脉压(MAP)较低以及利尿剂治疗剂量较大和持续时间较长。多因素分析中,收缩期功能障碍患者(40%)比舒张期功能障碍患者(28%)更频繁地发生ARI。观察到在收缩期LV功能障碍患者中使用地高辛可使ARI风险降低61%,这与用于治疗CHF患者的其他药物无关。
年龄、基线肾功能和血清钠浓度、MAP以及利尿剂治疗强度可识别在接受CHF利尿剂治疗时发生ARI风险的个体。这种并发症在收缩期功能障碍个体中更常见,使用地高辛可能会降低其风险。